What is Guardant360® CDx?
Guardant360 CDx is a liquid biopsy test that provides the answers your doctor needs to build your treatment plan.
As a blood test, Guardant360 CDx captures the DNA that is shed from your tumor. This provides a comprehensive overview of your cancer genomics from both your primary tumor and any metastatic sites. Guardant360 CDx examines 50+ clinically relevant genes to identify select genomic biomarkers specific to your cancer, while avoiding the complications and delays of a tissue biopsy.
Introduction to Guardant360 CDx from Guardant Health
When should Guardant360 CDx be considered?
Your doctor may order Guardant360 CDx for advanced cancer:
- On initial diagnosis
- If testing of your initial tissue biopsy is incomplete or inconclusive
- If your cancer is progressing on the current treatment
For the complete intended use statement, visit Guardant360CDx.com
Disclaimer: Data shown for the performance of Guardant360 Laboratory Developed Test (LDT) does not convey the performance of Guardant360 CDx.
Questions about Guardant360?
Call 855.698.8887 or email [email protected]